With the analysis among 770 patents, we discovered top 203 key players by total patent application. F. Hoffmann-La Roche Ltd., Intas Pharmaceuticals Ltd., Genentech, Inc. are dominant in this area. They take 22.60% of the total patent filing.
California, United States
Patent: 36
New Jersey, United States
Patent: 29
New Jersey, United States
Patent: 26
California, United States
Patent: 17
Massachusetts, United States
Patent: 17
California, United States
Patent: 14
With the analysis among 5 patents, we discovered top 5 start-ups by total patent application. NantOmics LLC, DRAGONFLY Therapeutics, Inc., Sumitomo Dainippon Pharma Oncology, Inc. are active in this area.
California, United States
Patent: 1
Massachusetts, United States
Patent: 1
Chiba-ken, Japan
Patent: 1
Guangdong Sheng, China
Patent: 1
With the analysis among related 141 patents applied in the last 5 years. We discover 62 most active companies in this area. The fast-growing Intas Pharmaceuticals Ltd., Odonate, Inc., Seagen Inc. take 24.82% of patent filing during this period.
California, United States
Patent: 10
Washington, United States
Patent: 7
Shandong Sheng, China
Patent: 4
California, United States
Patent: 4
Jiangsu Sheng, China
Patent: 3
Nanjing Juke Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 3
Guizhou Yongnuofit Biopharmaceutical Co., Ltd.
Guizhou Sheng, China
Patent: 2
With the analysis among related 141 patents in last 5 years, we discover 45 new entrants. Odonate, Inc., Seagen Inc., Cambridge Enterprise Ltd. are the most active new entrants in this area.
California, United States
Patent: 10
Washington, United States
Patent: 7
Nanjing Juke Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 3
Guizhou Yongnuofit Biopharmaceutical Co., Ltd.
Guizhou Sheng, China
Patent: 2
Shandong Sheng, China
Patent: 2
Chongqing Shi, China
Patent: 2
Jiangsu Sheng, China
Patent: 2
Guangdong Sheng, China
Patent: 2
Shanghai Shi, China
Patent: 2
With the analysis among 67 patents, we discovered top 20 universities and scientific research institutions by total patent application. Shanghai Institute of Materia Medica Chinese Academy of Sciences, New York University, Shanghai Institute of Pharmaceutical Industry are dominant in this area. They take 44.78% of the total patent filing.
Shanghai Shi, China
Patent: 5
New York, United States
Patent: 3
Shanghai Shi, China
Patent: 3
California, United States
Patent: 2
Jiangsu Sheng, China
Patent: 2
Jiangsu Sheng, China
Patent: 2
Guangdong Sheng, China
Patent: 1
Shaanxi Sheng, China
Patent: 1
Shanghai Shi, China
Patent: 1